siRNA therapy for Huntington's disease(University of Massachusetts Medical School/Lundbeck)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamesiRNA therapy for Huntington's disease(University of Massachusetts Medical School/Lundbeck)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHuntingtin inhibitors
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLundbeck LlcUniversity Of Massachusetts Medical School
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A